InvestorsHub Logo
Followers 16
Posts 4127
Boards Moderated 2
Alias Born 07/22/2004

Re: qawpol post# 1939

Friday, 06/01/2007 1:08:48 PM

Friday, June 01, 2007 1:08:48 PM

Post# of 6451
I agree with the failed trial description.

However, I question whether .50 is an accurate price for a company that will (in all likelyhood) have to run at least 1 and possibly 2 more Phase III trials ($5M cost if I recall), has no money now so will have to raise money, raised the previous $5M via a "toxic death spiral" financing, has a lawsuit pending against an earlier previous financing partner alleging illegal short selling of CLSC, and whom Cobalis still owes money to, and is likely to spend x months and x dollars in a losing cause trying to salvage the data from these 2 trials.

IMO, selling for .48 right now is the right choice, but as always time will tell.

There will undoubtedly be trading opportunities for those nimble enough to guess/predict the right entry and exit points, but to me the longer term writing is clearly on the wall now.

I sold my final shares at .48 a few moments ago.

P.S. My condolences to everyone who, like me, lost some money on this investment. And absolutely good luck to all remaining longs.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.